Straumann Holding AG Total Current Liabilities 2012-2021 | SAUHY

Straumann Holding AG total current liabilities from 2012 to 2021. Total current liabilities can be defined as the sum of all liabilities classified as current for having maturities of less than one year.
  • Straumann Holding AG total current liabilities for the quarter ending December 31, 2021 were $0.616B, a 121.37% increase year-over-year.
  • Straumann Holding AG total current liabilities for 2021 were $0.616B, a 52.11% increase from 2020.
  • Straumann Holding AG total current liabilities for 2020 were $0.405B, a 30.55% decline from 2019.
  • Straumann Holding AG total current liabilities for 2019 were $0.583B, a 109.56% increase from 2018.
Straumann Holding AG Annual Total Current Liabilities
(Millions of US $)
2021 $616
2020 $405
2019 $583
2018 $278
2017 $217
2016 $171
2015 $166
2014 $150
2013 $128
2012 $114
2011 $126
Straumann Holding AG Quarterly Total Current Liabilities
(Millions of US $)
2021-12-31 $616
2020-12-31 $405
2020-06-30 $448
2019-12-31 $583
2018-12-31 $278
2017-12-31 $217
2017-06-30 $172
2016-12-31 $171
2016-06-30 $169
2015-12-31 $166
2014-12-31 $150
2013-12-31 $128
2013-06-30 $112
2012-12-31 $114
2012-06-30 $146
2011-12-31 $126
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $22.515B $2.845B
The Straumann Group is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann currently employs approximately on thousand seven hundred ninety people worldwide and its products and services are available in more than sixty countries through its broad network of distribution subsidiaries and partners.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $75.918B 20.77
Becton Dickinson (BDX) United States $66.130B 16.56
Cardinal Health (CAH) United States $30.812B 16.50
Labcorp (LH) United States $21.029B 17.26
Cooper (COO) United States $17.974B 24.34
West Pharmaceutical Services (WST) United States $15.984B 32.75
Align Technology (ALGN) United States $14.238B 27.05
Henry Schein (HSIC) United States $9.680B 18.44
Merit Medical Systems (MMSI) United States $6.033B 30.81
DENTSPLY SIRONA (XRAY) United States $3.787B 10.30
Patterson (PDCO) United States $2.744B 14.66
CONMED (CNMD) United States $1.915B 14.90
STAAR Surgical (STAA) United States $0.800B 0.00
Lifevantage (LFVN) United States $0.211B 23.38
Pro-Dex (PDEX) United States $0.108B 16.47